Complete News, Your Way.

Published 1 day ago • loading... • Updated 1 day ago

Abbisko Therapeutics Completes First Patient Dosing in Registrational Study of Irpagratinib for HCC

Summary by Charleston Gazette-Mail

SHANGHAI, June 15, 2025 /PRNewswire/ -- Abbisko Therapeutics (HKEX Code: 02256) today announced that it has completed first patient dosing in a registrational study of irpagratinib, a self-developed and highly-selective small molecule FGFR4 inhibitor, for the treatment of Hepatocellular Carcinoma…

82 Articles

82 Articles

All

Left

10

Center

23

Right

5

Charleston Gazette-Mail

Watauga Democrat

NNY360

TBNweekly

Local 3 News

The State Journal

Delaware Business Now

The Laconia Daily Sun

Brattleboro Reformer

Islander News

The Progress

Record Argus - Serving Greenville, PA since 1848

Bennington Banner

The Berkshire Eagle

Rutland Herald

Suncoast News

Queens Chronicle

ashepostandtimes.com

waynecountynews.com

The Transylvania Times

The Coal Valley News

Alex City Outlook

Selma Sun

Hometown News Treasure Coast

The Advocate & Democrat

williamsondailynews.com

The Westerly Sun

The Logan Banner

Independent-Messenger

The Avery Journal-Times

winchesternewsgazette.com

mainstreetnews.com

thepilotnews.com

Cherokee Tribune Ledger News

MyHorryNews.com

The Times-News

LoudounTimes.com

Herald Chronicle

Hometown News Brevard

The Clarion News

Appalachian News-Express

therogersvillereview.com

coasttv.com

Altavista Journal

The Daily Press

Times Virginian

The Caswell Messenger

The Miami Times

The Ridgway Record

thesussexsurrydispatch.com

Brunswicktimes Gazette

kentuckytoday.com

coastaltvnews.com

willistonobserver.com

Observer News Enterprise

Carroll News

swrankinnews.com

blockislandtimes.com

Essex Reporter

Fairfax County Times

miltonindependent.com

Oswego County News Now

Rappahannock News

Community News

theohiopressnetwork.com

The Dispatch

SRI News

The News Progress

Westminster Cable Network

Florida Courier

Coastal Point

Loudoun Now

upstatetoday.com

The Inquirer and Mirror

Daytona Times

dailytimesleader.com

delmarvasportsnetwork.com

www.Arundel.News

mountaineagle.com

miltontimes.com

Lincoln Times News

+81 Reposted by 81 other sources

Abbisko Therapeutics Completes First Patient Dosing in Registrational Study of Irpagratinib for HCC

SHANGHAI, June 15, 2025 /PRNewswire/ -- Abbisko Therapeutics (HKEX Code: 02256) today announced that it has completed first patient dosing in a registrational study of irpagratinib, a self-developed and highly-selective small molecule FGFR4 inhibitor, for the treatment of Hepatocellular Carcinoma…

1 day ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Coverage Details

Total News Sources82

Leaning Left10Leaning Right5Center23Last Updated5 hours agoBias Distribution

61% Center

Bias Distribution

61% of the sources are Center

61% Center

+5

+18

Untracked bias

+35

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Charleston Gazette-Mail broke the news in Charleston, United States 1 day ago on Monday, June 16, 2025.

Sources are mostly out of (0)

Similar News Topics

Similar News Topics